Apontis Pharma AG (APPH.DE)
EUR 11.25
(0.45%)
EUR 11.25
(0.45%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 36.96 Million EUR | -33.6% |
| 2022 | 55.72 Million EUR | 8.87% |
| 2021 | 51.18 Million EUR | 30.44% |
| 2020 | 39.24 Million EUR | -1.99% |
| 2019 | 40.03 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 22.72 Million EUR | 26.92% |
| 2023 Q2 | 19.05 Million EUR | -31.0% |
| 2023 Q4 | 17.9 Million EUR | -6.05% |
| 2023 FY | 37 Million EUR | -33.6% |
| 2022 Q2 | 28.1 Million EUR | 3.45% |
| 2022 FY | 55.72 Million EUR | 8.87% |
| 2022 Q4 | 27.61 Million EUR | -1.74% |
| 2021 FY | 51.18 Million EUR | 30.44% |
| 2021 Q4 | 27.17 Million EUR | 13.16% |
| 2021 Q2 | 24.01 Million EUR | 0.0% |
| 2020 FY | 39.24 Million EUR | -1.99% |
| 2019 FY | 40.03 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| MPH Health Care AG | 34.43 Million EUR | -7.358% |
| Dermapharm Holding SE | 1.13 Billion EUR | 96.744% |
| Evotec SE | 781.42 Million EUR | 95.27% |
| MERCK Kommanditgesellschaft auf Aktien | 20.99 Billion EUR | 99.824% |
| PharmaSGP Holding SE | 101.09 Million EUR | 63.438% |
| SynBiotic SE | 3.86 Million EUR | -857.275% |